Tag Archives: AstraZeneca US phase 3 trials

AstraZeneca Covid-19 vaccine US phase 3 trials: 79% efficacy; no thrombosis (blot clotting)…

.. 2. The study involving more than 30,000 participants, also revealed that AstraZeneca's Covid-19 vaccine was 100% effective against critical disease and hospitalisation. The drugmaker adds that the vaccine was 80% effective at preventing the disease in the elderly. — … Continue reading

Posted in Uncategorized | Tagged | Leave a comment